InsidersTradesSigma
Track the AYTU BIOSCIENCE, INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 21 January 2016 (Acquisition). Among the most active insiders: Disbrow Jarrett. The full history is accessible without an account.
Analysts rate AYTU BIOSCIENCE, INC Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
AYTU BIOSCIENCE, INC 是一家专注于药品和医疗器械开发及商业化的公司。它旨在为未满足的医疗需求提供创新解决方案。